Cornejo-Plaza M, Saracini C
Front Psychol. 2023; 14:1177720.
PMID: 37533709
PMC: 10393253.
DOI: 10.3389/fpsyg.2023.1177720.
Becke M, Tucha L, Weisbrod M, Aschenbrenner S, Tucha O, Fuermaier A
J Neural Transm (Vienna). 2021; 128(7):1045-1063.
PMID: 33651237
PMC: 8295107.
DOI: 10.1007/s00702-021-02318-y.
Mayor E, Daehne M, Bianchi R
BMC Psychol. 2020; 8(1):119.
PMID: 33160397
PMC: 7648998.
DOI: 10.1186/s40359-020-00486-2.
Napoletano F, Schifano F, Corkery J, Guirguis A, Arillotta D, Zangani C
Front Psychiatry. 2020; 11:546796.
PMID: 33024436
PMC: 7516264.
DOI: 10.3389/fpsyt.2020.546796.
Ricci G
Front Psychiatry. 2020; 11:53.
PMID: 32127792
PMC: 7037021.
DOI: 10.3389/fpsyt.2020.00053.
Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue.
Zaami S, Tagliabracci A, Berretta P, Busardo F, Marinelli E
Front Psychiatry. 2020; 10:1006.
PMID: 32038333
PMC: 6989549.
DOI: 10.3389/fpsyt.2019.01006.
The brain as an agentic system: how the brain is articulated in the field of neuroenhancement.
Brenninkmeijer J
Sociol Health Illn. 2018; 41(1):112-127.
PMID: 30155996
PMC: 7379945.
DOI: 10.1111/1467-9566.12810.
From 'Hard' Neuro-Tools to 'Soft' Neuro-Toys? Refocussing the Neuro-Enhancement Debate.
Brenninkmeijer J, Zwart H
Neuroethics. 2017; 10(3):337-348.
PMID: 28890737
PMC: 5569123.
DOI: 10.1007/s12152-016-9283-6.
Do college students improve their grades by using prescription stimulants nonmedically?.
Arria A, Caldeira K, Vincent K, OGrady K, Cimini M, Geisner I
Addict Behav. 2016; 65:245-249.
PMID: 27469455
PMC: 5140739.
DOI: 10.1016/j.addbeh.2016.07.016.
Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study.
Hildt E, Lieb K, Bagusat C, Franke A
Biomed Res Int. 2015; 2015:621075.
PMID: 26064931
PMC: 4433654.
DOI: 10.1155/2015/621075.
Cognitive Enhancement: Perceptions Among Parents of Children with Disabilities.
Ball N, Wolbring G
Neuroethics. 2014; 7(3):345-364.
PMID: 25431631
PMC: 4241232.
DOI: 10.1007/s12152-014-9201-8.
Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate.
Maslen H, Faulmuller N, Savulescu J
Front Syst Neurosci. 2014; 8:107.
PMID: 24999320
PMC: 4052735.
DOI: 10.3389/fnsys.2014.00107.
The value and pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement.
Racine E, Rubio T, Chandler J, Forlini C, Lucke J
Med Health Care Philos. 2014; 17(3):325-37.
PMID: 24402841
DOI: 10.1007/s11019-013-9539-4.
Enhancement stimulants: perceived motivational and cognitive advantages.
Ilieva I, Farah M
Front Neurosci. 2013; 7:198.
PMID: 24198755
PMC: 3813924.
DOI: 10.3389/fnins.2013.00198.
Adderall for All: A Defense of Pediatric Neuroenhancement.
Flanigan J
HEC Forum. 2013; .
PMID: 23959502
DOI: 10.1007/s10730-013-9222-4.
Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians.
Singh I, Filipe A, Bard I, Bergey M, Baker L
Curr Psychiatry Rep. 2013; 15(9):385.
PMID: 23933975
DOI: 10.1007/s11920-013-0385-0.
Smart drugs "as common as coffee": media hype about neuroenhancement.
Partridge B, Bell S, Lucke J, Yeates S, Hall W
PLoS One. 2011; 6(11):e28416.
PMID: 22140584
PMC: 3227668.
DOI: 10.1371/journal.pone.0028416.
